From Associated Press (February 5, 2010)
WASHINGTON -- Federal health officials warned doctors Friday that
the risk of a deadly brain inflammation linked to the multiple
sclerosis treatment Tysabri increases with use of the drug.
Tysabri has been... (Source: Drugs.com - Pharma News)
Posted: 2010-02-08 06:20:30
More from this author:
Multiple Sclerosis: What Part Do Relapses Play In Severe Disability?
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Multiple Sclerosis Relapses and Severe Disability
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis.
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Stress, Fear, Anxiety and MS
From the Web > About.com Multiple Sclerosis: Most Popular Article
From the Web > About.com Multiple Sclerosis: Most Popular Article
Puusepp's sign—Clinical significance of a forgotten pyramidal sign
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Related Articles:
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis.
From the Web > MedWorm: Multiple Sclerosis
Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Newly Diagnosed With Multiple Sclerosis - Now What?
From the Web > Health and Fitness: Diseases Multiple Sclerosis Ar
Modulation of serum uric acid levels by inosine in patients with multiple sclerosis does not affect blood pressure
From the Web > MedWorm: Multiple Sclerosis
Sample size requirements for treatment effects using gray matter, white matter and whole brain volume in relapsing-remitting multiple sclerosis
From the Web > MedWorm: Multiple Sclerosis
